Foot Moisturizing & Callus Reduction
By the end of this lesson, the learner will be able to:
- Explain how callus formation is driven by repetitive pressure and friction, and why moisturizing alone won't resolve a callus without addressing the underlying cause.
- Select an appropriate emollient or keratolytic agent based on skin condition and patient risk profile, including urea concentration ranges.
- Demonstrate gradual mechanical callus reduction using safe, single-use abrasives — and explain why razors and aggressive single-session reduction are unsafe.
- Identify products and techniques that are contraindicated in patients with diabetes, PAD, or peripheral neuropathy.
- Educate patients on safe at-home moisturizing technique, including the "no lotion between toes" rule.
Module 3 Lesson 3 covered the diagnosis of hyperkeratotic conditions — what calluses, corns, and verrucae are and how to tell them apart. This lesson focuses on treatment technique: how to safely reduce a callus, how to choose the right moisturizer for the situation, and which patients require special caution. The two skills go together because moisturizing without reducing the callus rarely works, and reducing the callus without addressing pressure and friction guarantees recurrence.
Why Hydration and Callus Care Matter
How Calluses Form: The Pressure Cycle
A callus is the skin's protective response to repetitive mechanical stress. Understanding the cycle is what tells you why mechanical reduction alone — without addressing the source of pressure — leads to immediate recurrence.
Mechanical reduction without addressing footwear, gait abnormality, or weight distribution is a temporary fix — the callus will reform within weeks. The complete intervention is: reduce the existing callus + identify the pressure source + correct it (footwear adjustment, padding, orthotic referral, gait assessment).
Choosing the Right Moisturizer
Not all foot moisturizers are equivalent. The right product depends on the skin condition and patient risk profile. Urea concentration is the most clinically meaningful variable — it determines whether the product is acting as a moisturizer, a mild keratolytic, or an aggressive keratolytic.
Routine hydration for healthy skin or mild dryness. Acts primarily as a humectant.
Mid-strength formulation — humectant plus mild keratolytic action. The workhorse for callused, thickened skin.
Aggressive softening of severely thickened or hardened skin. Often available by prescription.
Lactic acid 5–12% products are an alternative humectant-keratolytic class — also evidence-supported for hyperkeratosis. Glycerin and ceramide-based products are good for general moisturization in patients who tolerate them. Petrolatum-based ointments are heavy occlusives — useful overnight under socks for very dry skin, but messy. Avoid scented/colored lotions in patients with sensitive or compromised skin — fragrance is a common contact dermatitis trigger.
The Gradual Reduction Principle
Aggressive single-session callus reduction is a leading cause of iatrogenic skin injury in foot care. The correct approach is conservative reduction across multiple visits, paired with daily moisturizing at home.
Standard Procedure: Callus Reduction
Confirm what you're treating: is it a callus (broad, diffuse), a corn (small, focal, often with central core), or a verruca (different etiology — see Module 3 Lesson 3 for differentiation). Inspect surrounding skin for signs of fissuring, infection, or sub-callus changes.
Skin should be clean and dry. A brief warm water rinse may slightly soften the surface, but prolonged soaking is not recommended — it removes natural oils, increases maceration risk, and can be harmful in diabetic patients. If the callus is very thick, apply a urea-based product 24–48 hours before the visit (patient education) rather than soaking in-clinic.
Use single-use foot files, single-use disposable pumice, or autoclaved metal foot rasps. Light pressure, broad strokes, frequent reassessment. Stop when the skin is noticeably smoother — not when the callus is "all gone." The goal of one session is partial reduction; complete resolution comes across multiple visits.
Confirm skin integrity. Any pinpoint bleeding, sub-callus changes, or unexpected findings get addressed before the patient leaves. Any visible bleeding generally means you went too deep — note this and reduce more conservatively next time.
Apply a urea-based emollient (10–25% depending on skin status) and instruct the patient on daily home application. Specifically educate on the "no lotion between toes" rule (interdigital moisture promotes maceration and dermatophyte growth).
Footwear assessment, padding for high-pressure areas (metatarsal pads, gel cushions), referral to podiatry for orthotics or to PT for gait assessment if indicated. Without this step, the callus will reform.
Typically every 4–8 weeks for active callus management, adjusted for the patient's IWGDF risk category (see Module 5 Lesson 1). Document the reduction technique, products used, patient response, and follow-up plan.
Special Considerations: Diabetes, PAD, and Neuropathy
Several common moisturizing and callus-care practices are contraindicated or require modification in patients with diabetes, PAD, or peripheral neuropathy. Knowing these is core CFCN content.
Avoid in diabetes, PAD, neuropathy. Chemical injury risk through insensate skin can cause unrecognized ulceration. Recommend mechanical reduction instead.
Avoid prolonged soaking (more than a few minutes). Soaking strips natural oils, increases maceration, and in patients who can't sense temperature reliably, scalding is a real risk.
Never recommend or perform on any patient as routine nursing care; absolutely contraindicated in this population. Sharp debridement is podiatry-level scope.
Most contain salicylic acid. Patient self-treatment with these products is a frequent precursor to ulcer development in diabetic patients.
Universally avoided regardless of diabetes status, but especially important here — interdigital maceration is a portal for tinea pedis and bacterial infection.
Even with mechanical tools, aggressive reduction in a single visit risks pinpoint bleeding and unrecognized injury. Conservative, multi-visit reduction is the standard.
If you reduce a callus and find dark discoloration, fluctuance, drainage, or an underlying ulcer, this is a "callus over wound" presentation — the callus is hiding ulceration. Stop, document the finding, and escalate to medical evaluation immediately. Do not continue routine reduction. In diabetic patients, sub-callus ulceration is one of the most common pathways to limb-threatening infection.
Common Mistakes & How to Avoid Them
Home-Care Education for Patients
Daily moisturizing: Apply a urea-based emollient (your provider can recommend the right strength) once or twice daily to the heels, soles, and dorsum of the foot. Never between the toes — this promotes fungal infection. Between visits: Use a foot file or single-use pumice once or twice a week, gently, on dry skin. Stop when the skin feels smooth — never push through to bleeding. What not to do: No razor blades. No OTC corn-removing pads if you have diabetes. No prolonged hot soaks. When to call: Any cut, fissure, or break in the skin that doesn't heal within a few days; any redness, swelling, drainage, or unusual discoloration; any pain that wasn't there before.
Case Studies
- Inspected heels carefully; documented fissure depth, no signs of active infection or sub-callus change
- Gentle mechanical reduction of surrounding hyperkeratotic rim using single-use file
- Counseled patient to discontinue salicylic acid pads — explained the chemical-injury risk in diabetic neuropathy
- Recommended urea 25% cream twice daily to heels and soles, never between toes
- Discussed footwear: closed-back shoes during healing; reviewed daily foot inspection
- Coordinated with PCP on diabetes management; scheduled 4-week follow-up given Risk 2 status
- Assessed footwear — running shoes with worn-down forefoot cushioning
- Conservative reduction with single-use file; emphasized smoothness, not complete removal
- Recommended urea 20% cream daily; discussed home filing technique
- Provided metatarsal pad samples for trial; counseled on shoe replacement intervals
- Referred to sports podiatry for biomechanical assessment given recurrent pattern
- Scheduled 8-week follow-up to evaluate response
- Callus formation is a pressure cycle — reduction without addressing the pressure source guarantees recurrence
- Match urea concentration to the clinical situation: 10% for maintenance, 20–25% for hyperkeratosis, 40%+ for severe (with caution in diabetes)
- Reduce gradually across multiple visits; aggressive single-session reduction is unsafe
- Avoid salicylic acid, razors, and prolonged foot soaks in patients with diabetes, PAD, or neuropathy
- Never apply moisturizer between the toes — interdigital moisture promotes fungal and bacterial infection
- If you find sub-callus changes, drainage, dark discoloration, or fluctuance — stop and escalate; this is a covered ulcer until proven otherwise
Ready to check your understanding? Take the quick knowledge check for this lesson.
Next up: Module 6 — Infection Prevention & Safety.
The information on this website and any communication with RNscrub Foot Care is provided for educational and informational purposes only. It is not a substitute for medical advice, diagnosis, or treatment. Patients are always encouraged to consult with their primary care provider or appropriate specialist for individual clinical decisions.
References
- International Working Group on the Diabetic Foot (IWGDF). IWGDF Guidelines on the Prevention and Management of Diabetes-Related Foot Disease. 2023.
- American Diabetes Association. Standards of Care in Diabetes — Foot Care. Diabetes Care. 2024;47(Suppl 1).
- Pan M, Heinecke G, Bernardo S, Tsui C, Levitt J. Urea: a comprehensive review of the clinical literature. Dermatology Online Journal. 2013;19(11):20392.
- Federici A, Federici G, Milani M. An urea, arginine and carnosine based cream (Ureadin Rx Db ISDIN) shows greater efficacy in the treatment of severe xerosis of the feet in Type 2 diabetic patients in comparison with standard glycerol-based emollient cream. BMC Dermatology. 2012;12:16.
- Bristow IR, Bower CA. Foot Problems and Their Management in the Athlete. In: Neale's Disorders of the Foot. 8th ed. Churchill Livingstone Elsevier; 2010.
- Vlahovic TC, Schleicher SM. Skin Disease of the Lower Extremities: A Photographic Guide. HMP Communications; 2012.
- Bus SA, Lavery LA, Monteiro-Soares M, et al. Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2019/2023 update). Diabetes/Metabolism Research and Reviews. 2020;36(S1):e3269.

